Traders sold shares of Humana Inc (NYSE:HUM) on strength during trading hours on Friday. $23.81 million flowed into the stock on the tick-up and $51.94 million flowed out of the stock on the tick-down, for a money net flow of $28.13 million out of the stock. Of all stocks tracked, Humana had the 0th highest net out-flow for the day. Humana traded up $1.33 for the day and closed at $325.04
Several equities research analysts recently commented on HUM shares. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday. Citigroup reaffirmed a “buy” rating and issued a $340.00 price objective (up previously from $280.00) on shares of Humana in a research report on Friday, June 1st. Argus increased their price objective on shares of Humana from $270.00 to $330.00 and gave the company a “buy” rating in a research report on Monday, April 16th. Oppenheimer increased their price objective on shares of Humana from $305.00 to $311.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Finally, Jefferies Financial Group increased their price objective on shares of Humana from $356.00 to $372.00 and gave the company a “buy” rating in a research report on Thursday, August 2nd. Seven analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $318.17.
The company has a market cap of $44.60 billion, a P/E ratio of 25.35, a P/E/G ratio of 1.61 and a beta of 0.93. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.47.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 1st. The insurance provider reported $3.96 EPS for the quarter, topping analysts’ consensus estimates of $3.79 by $0.17. The company had revenue of $14.26 billion for the quarter, compared to analyst estimates of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same quarter in the previous year, the firm earned $3.49 earnings per share. analysts expect that Humana Inc will post 14.18 EPS for the current year.
In other news, SVP Cynthia H. Zipperle sold 1,000 shares of the company’s stock in a transaction dated Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total transaction of $306,010.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Elizabeth D. Bierbower sold 6,036 shares of the company’s stock in a transaction dated Monday, June 11th. The stock was sold at an average price of $300.91, for a total value of $1,816,292.76. Following the transaction, the insider now directly owns 21,683 shares of the company’s stock, valued at $6,524,631.53. The disclosure for this sale can be found here. Insiders have sold 104,976 shares of company stock valued at $32,165,337 over the last ninety days. 0.60% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Synovus Financial Corp bought a new position in shares of Humana during the first quarter worth approximately $100,000. Sun Life Financial INC increased its stake in Humana by 120.7% during the 2nd quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after acquiring an additional 204 shares during the period. Financial Gravity Wealth Inc. bought a new position in Humana during the 1st quarter worth $113,000. Migdal Insurance & Financial Holdings Ltd. increased its stake in Humana by 2,984.6% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 388 shares during the period. Finally, Stratos Wealth Partners LTD. increased its stake in Humana by 448.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 417 shares of the insurance provider’s stock worth $112,000 after acquiring an additional 341 shares during the period. 93.78% of the stock is owned by hedge funds and other institutional investors.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
See Also: Diversification in Investing
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.